Agios Pharmaceuticals, Inc.AGIONASDAQ
Loading
Research and development spending
3Y CAGR
+6.5%/yr
vs -4.8%/yr prior
5Y CAGR
+9.9%/yr
Recent deceleration
Acceleration
+11.4pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $338.28M | +12.3% |
| 2024 | $301.29M | +4.3% |
| 2023 | $288.90M | +3.2% |
| 2022 | $279.91M | +8.9% |
| 2021 | $256.97M | +21.8% |
| 2020 | $211.02M | -48.6% |
| 2019 | $410.89M | +20.4% |
| 2018 | $341.32M | +16.6% |
| 2017 | $292.68M | +32.9% |
| 2016 | $220.16M | - |